217. Back to Basics - Advanced Ovarian Cancer

217. Back to Basics - Advanced Ovarian Cancer

Up next

218. Back to Basics - Endometrial Cancer

This week we cover endometrial cancer. It is one of the clearest examples of molecular classification changing how we treat patients. PORTEC-3 randomised women with high-risk disease to pelvic radiotherapy with or without chemotherapy. Adding chemotherapy improved survival, and t ...  Show more

216. Back to Basics - Early Ovarian Cancer

Our Back to Basics odyssey nears its end, a journey just as epic as Matt Damon's (we think so, anyway). As we enter the final stretch, we discuss ovarian cancer, a cancer with significant mortality and morbidity despite advances in treatment. In this episode Josh and Michael disc ...  Show more

Recommended Episodes

Immunotherapy in TNBC: What's New, What's Next?
Medscape InDiscussion: Triple-Negative Breast Cancer

Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991253). The ...  Show more

Radiation Oncology and the Abscopal Effect in TNBC
Medscape InDiscussion: Triple-Negative Breast Cancer

What does the cutting edge of radiation oncology look like for treating triple-negative breast cancer? Tune in to hear experts Drs Kevin Kalinsky and Reshma Jagsi discuss. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarti ...  Show more

Hereditary Breast Cancer, Genetic Testing, and Therapeutic Implications
Medscape InDiscussion: Triple-Negative Breast Cancer

Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991258). The topics and discussions ...  Show more